Pharmacokinetic Alterations During ECMO

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

August 31, 2015

Conditions
Acute Respiratory Failure
Interventions
DRUG

Ketamine

Ketamine will be initiated as a one-time 40 mg bolus of ketamine followed by a continuous intravenous infusion of 5 micrograms/kg/min at the start of ECMO.

OTHER

Sedative drug regimen

(Standard of Care) Fentanyl or hydromorphone and midazolam infusions will be administered to all patients and titrated at the discretion of the attending physician to maintain the desired level of sedation.

Trial Locations (1)

10032

NewYork-Presbyterian Hospital, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT01938079 - Pharmacokinetic Alterations During ECMO | Biotech Hunter | Biotech Hunter